Progenics Pharmaceuticals, Inc. Announces Retirement of Founder Paul J. Maddon
TARRYTOWN, N.Y., March 15, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that company founder Paul J. Maddon, M.D., Ph.D. has retired as chief science officer of the company. He continues as a member and vice chair of the Progenics board of directors.